Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Quinto J. Gesiotto"'
Autor:
David M. Swoboda, Rashmi Kanagal-Shamanna, Andrew M. Brunner, Thomas Cluzeau, Onyee Chan, Najla Al Ali, Guillermo Montalban-Bravo, Quinto J. Gesiotto, Alexander Gavralidis, Anthony M. Hunter, Jung-Hoon Lee, Andrew T. Kuykendall, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Eric Padron, Mohammad Hussaini, Jinming Song, Guillermo Garcia-Manero, Rami S. Komrokji, David A. Sallman
Publikováno v:
Leukemia. 36(4)
Autor:
Ashley Rose, Quinto J Gesiotto, Leidy Isenalumhe, Farhad Khimani, Hien D. Liu, Sameh Gaballa, Julio C. Chavez, Bijal D. Shah, Javier Pinilla Ibarz, Celeste Bello, Lubomir Sokol, Hayder Saeed
Publikováno v:
Blood. 138:2913-2913
Introduction: The standard of care for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous hematopoietic stem cell transplant (auto-HCT). Pre-apheresis absolute lymphocyte count (PA-ALC) is an independ
Autor:
Quinto J Gesiotto, David M Swoboda, Najla E. Al Ali, Eric Padron, Andrew T. Kuykendall, Jinming Song, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Rami Komrokji, David A. Sallman
Publikováno v:
Blood. 136:4-5
Background: Checkpoint inhibitors, for example anti-PD-1 antibodies (e.g. nivolumab and pembrolizumab) and anti-CTLA-4 antibodies (e.g. ipilimumab), have changed the paradigm of many solid tumors although in myeloid malignancies responses have been l